Chronic myeloproliferative disease

chronic myeloproliferative disorder: A clonal hematopoietic stem cell disorder, characterized by proliferation in the bone marrow of one or more of the myeloid (i.e., granulocytic, erythroid, megakaryocytic, and mast cell) lineages. It is primarily a neoplasm of adults. (WHO 2008)

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries Inpat., Oupat., Death

Hospital Discharge: ICD-10 D47.1
Cause of death: ICD-10 D47.1

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector CHRONMYELOPRO

Extra metadata

First used in FinnGen datafreeze DF2, additional

Summary Statistics

Key figures

All Female Male
Number of individuals 137 61 76
Unadjusted prevalence (%) 0.05 0.04 0.07
Mean age at first event (years) 63.75 62.83 64.48

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Correlations

Index endpoint: CHRONMYELOPRO – Chronic myeloproliferative disease
GWS hits: 1

Survival analyses between endpoints

Plot

before Chronic myeloproliferative disease
after Chronic myeloproliferative disease

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Chronic myeloproliferative disease